Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
---|
04/21/2005 | WO2005035506A1 Novel indazole derivative |
04/21/2005 | WO2005034945A1 Use of norphenazone and coenzyme q for curing arthrose, arthritis and osteoarthritis |
04/21/2005 | WO2005034939A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
04/21/2005 | WO2005034850A2 Cycloalkyl heterocycles for treating hepatitis c virus |
04/21/2005 | WO2005014525A3 Bi-aryl compound having immunosuppressive activity |
04/21/2005 | WO2004062601A3 Antibacterial agents |
04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
04/21/2005 | US20050085524 Fungicides, bactericides, insecticides |
04/21/2005 | US20050085517 Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
04/21/2005 | US20050085512 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
04/21/2005 | US20050081746 Inkjet dye design |
04/21/2005 | US20050081312 1-(2,4-dimethylphenyl)-4,5-diamino-1H-pyrazole dihydrochloride, ready-to-apply dyeing mixture for oxidative dyeing; brilliant color shades, improved color resistance to shampooing on hair varying greatly in quality, particularly on hair damaged by permanent waving or bleaching |
04/21/2005 | CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
04/21/2005 | CA2539878A1 Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics |
04/21/2005 | CA2539587A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
04/20/2005 | EP1523475A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
04/20/2005 | EP1177185B1 4, 5, 6, 7-tetrahydroindazole derivatives as antitumor agents |
04/20/2005 | CN1608050A Piperazine derivative |
04/19/2005 | US6881848 Process for preparing 4-trifluoromethylsulfinylpyrazole derivative |
04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
04/14/2005 | WO2005000281A3 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
04/14/2005 | WO2004099154A3 Pyrazole-amides and sulfonamides as sodium channel modulators |
04/14/2005 | US20050080124 Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot |
04/14/2005 | US20050080121 for example, 4S-[(naphthalene-2-carbonyl)-amino]-5-(2-oxo-pyrrolidin-3S-yl)-pent-2-enoic acid ethyl ester; treatment of viral infections caused by human rhinoviruses, human polioviruses, human coxsackieviruses, human echoviruses, among others |
04/14/2005 | US20050080106 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
04/14/2005 | US20050080087 For treatment of metabolic disorders, eating disorders, appetitive disorders, psychiatric disorders, memory impairment, Parkinson's disease, Alzheimer's disease, substance abuse, leukocyte activation-associated disorders, and inflammatory diseases |
04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |
04/14/2005 | US20050079979 Substituted benzoylisoxazoles and the use thereof as herbicides |
04/14/2005 | DE10337496A1 4-Biphenylsubstituierte-4-substituierte-pyrazolidin-3,5-dione 4-biphenyl-4-substituted-pyrazolidine-3,5-diones |
04/13/2005 | EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia |
04/13/2005 | CN1606546A Novel substituted pyrazole derivative, process for producing the same, and herbicidal composition containing the same |
04/13/2005 | CN1606544A Bicyclic compound |
04/12/2005 | US6878729 Antihypoxic agents |
04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
04/07/2005 | WO2005030901A1 Organic electroluminescent device |
04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
04/07/2005 | WO2005030702A1 Biphenyloxy-acids |
04/07/2005 | WO2005030699A1 Substituted benzanilide compound and pest control agent |
04/07/2005 | WO2005030128A2 Pyrazole modulators of metabotropic glutamate receptors |
04/07/2005 | WO2005019147A3 Pesticidally active phenol derivatives |
04/07/2005 | WO2005016873A3 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives |
04/07/2005 | WO2005012256A8 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
04/07/2005 | US20050075390 HIV protease inhibitors |
04/07/2005 | US20050075378 Modulators of peroxisome proliferator activated receptors (ppar) |
04/07/2005 | US20050075376 for inhibiting hepatitis C NS5B RNA-dependent RNA polymerase; exemplified by ethyl 1-cyclohexyl-5-(4-benzyloxyphenyl)-1H-pyrazole-3-carboxylate |
04/07/2005 | US20050075372 Method for controlling particular insect pest by applying anthranilamide compounds |
04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
04/07/2005 | CA2539250A1 Biphenyloxy-acids |
04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
04/06/2005 | EP1257275B1 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |
04/06/2005 | EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
04/06/2005 | EP0853449B1 Poison baits containing n-phenyl or n-pyridyl pyrazoles for controlling insect pests |
04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
04/06/2005 | CN1604894A 经取代的苯基衍生物 Substituted phenyl derivatives |
04/06/2005 | CN1604889A Method for producing 2-halogenacyl-3-amino-acrylic acid derivatives |
04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
04/05/2005 | US6875786 Promoters of bone marrow cells |
04/05/2005 | US6875785 Nonsteroidal antiinflammatory agents, e.g., N-hydroxy-1-(4-sulfonyl or aminosulfonyl)phenyl)-(ring- substituted hetero-cyclyl)alkanamide or -urea; dual enzyme inhibitors with minimal side effects; asthma; antiallergens; antipyretics |
04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
03/31/2005 | WO2005028445A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
03/31/2005 | WO2005028429A2 Haloalkyl containing compounds as cysteine protease inhibitors |
03/31/2005 | WO2005009947A3 Aryl heteroaromatic products, compositions comprising the same and use thereof |
03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
03/31/2005 | WO2004098591A3 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
03/31/2005 | WO2004096212A9 Pyrazole compounds as hsp90 inhibitors for the treatment of cancer |
03/31/2005 | WO2004092139A3 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
03/31/2005 | WO2004073606A3 Sulfonamide derivatives as ppar modulators |
03/31/2005 | WO2004008837A3 Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them |
03/31/2005 | US20050070589 Pyrazolyl inhibitors of 15- lipoxygenase |
03/31/2005 | US20050070539 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
03/31/2005 | US20050070441 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient |
03/31/2005 | US20050069912 Energy transfer dyes with enhanced fluorescence |
03/31/2005 | US20050069555 Vaccine adjuvants; hepatitis c virus; modulation immunology response |
03/31/2005 | CA2538454A1 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain |
03/31/2005 | CA2537916A1 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
03/31/2005 | CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors |
03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
03/30/2005 | EP1517898A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
03/30/2005 | EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
03/30/2005 | EP1075467B1 Pyrazole derivatives as p-38 map kinase inhibitors |
03/30/2005 | CN1602314A Copper deposition method using copper formate complexes |
03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
03/29/2005 | US6872741 Sodium channel modulators |
03/24/2005 | WO2005026128A1 Ophthalmic compositions for treating ocular hypertension |
03/24/2005 | WO2005026127A1 Plasminogen activator inhibitor-1 inhibitor |
03/24/2005 | WO2005025555A2 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |
03/24/2005 | WO2004039795A3 Amide compounds for the treatment of hyperlipidemia |
03/24/2005 | US20050065350 Method for forming a carbon-carbon or carbon-heteroatom linkage |
03/24/2005 | US20050065095 Antibacterial agents |
03/24/2005 | US20050065033 Method to inhibit ethylene responses in plants |